Transparently report on the process of moving from evidence to recommendation

Affiliations

¹ Chevidence Lab of Child and Adolescent Health, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China; International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, 400014, China; Chongqing Key Laboratory of Pediatrics, Chongqing, China.
² School of Public Health, Lanzhou University, Lanzhou, China.
³ Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China.
⁴ Chevidence Lab of Child and Adolescent Health, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China; International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, 400014, China; Chongqing Key Laboratory of Pediatrics, Chongqing, China; Research Unit of Evidence-Based Evaluation and Guidelines, Chinese Academy of Medical Sciences, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China. Electronic address: chenyaolong@lzu.edu.cn.

Comment

Meng Lv et al. Lancet Haematol. 2022 Jul.

. 2022 Jul;9(7):e472.

doi: 10.1016/S2352-3026(22)00170-3.

¹ Chevidence Lab of Child and Adolescent Health, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China; International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, 400014, China; Chongqing Key Laboratory of Pediatrics, Chongqing, China.
² School of Public Health, Lanzhou University, Lanzhou, China.
³ Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China.
⁴ Chevidence Lab of Child and Adolescent Health, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China; International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, 400014, China; Chongqing Key Laboratory of Pediatrics, Chongqing, China; Research Unit of Evidence-Based Evaluation and Guidelines, Chinese Academy of Medical Sciences, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China. Electronic address: chenyaolong@lzu.edu.cn.

No abstract available

Conflict of interest statement

We declare no competing interests.

Transparently report on the process of moving from evidence to recommendation - Authors' reply.
Stemler J, Skoetz N, Cornely OA. Stemler J, et al. Lancet Haematol. 2022 Jul;9(7):e472-e473. doi: 10.1016/S2352-3026(22)00180-6. Lancet Haematol. 2022. PMID: 35772424 No abstract available.

Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association.
Stemler J, de Jonge N, Skoetz N, Sinkó J, Brüggemann RJ, Busca A, Ben-Ami R, Ráčil Z, Piechotta V, Lewis R, Cornely OA. Stemler J, et al. Lancet Haematol. 2022 May;9(5):e361-e373. doi: 10.1016/S2352-3026(22)00073-4. Lancet Haematol. 2022. PMID: 35483397